Literature DB >> 10215966

Anaphylaxis following the use of a plasma-derived immunopurified monoclate-P, and the recombinant Recombinate and Kogenate factor VIII: a therapeutic challenge.

G Pernod, C Armari, C Barro, D Plantaz, D Caperan, C Jacquot, B Polack.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215966

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  1 in total

1.  Anaphylaxis after treatment with recombinant factor VIII: investigation and therapeutic challenge.

Authors:  Sofia Pires; Teresa Sevivas; Carla Chaves Loureiro; Borja Bartholomé
Journal:  BMJ Case Rep       Date:  2018-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.